se of Venlafaxine in the treatment of adult attention deficit hyperactivity disorder
Phase 2
- Conditions
- Adult ADHD (Attention-deficit hyperactivity disorder ).Hyperkinetic disorders
- Registration Number
- IRCT138808122660N1
- Lead Sponsor
- Vice Chancellor for Research of Tabriz Univercity of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1. Age between 18-45 year 2. Having Adult attention deficit hyperactivity disorder (ADHD) according to the judgment of two psychiatrists 3. Confirm of ADHD symptoms at childhood period.
Exclusion criteria: 1. Evidence of mental retardation ( IQ<70 based on clinical judgment ) 2. Other psychiatric comorbidity 3. Any significant chronic medical condition, including organic brain disorder and seizure 4. Current abuse or dependence on substance within 6 months 5. Pregnant and lactating women . 6. use any psychiatirc drugs in recent two weeks
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Attention-deficit symptoms. Timepoint: weeks 2, 4 and 6. Method of measurement: According to the self-report Conner's questionnaire.;Improvement in impulsivity. Timepoint: weeks 2, 4 and 6. Method of measurement: According to the Self-report Conner's questionnaire.;Improvement in hyperactivity symptoms. Timepoint: weeks 2, 4 and 6. Method of measurement: According to the Self-report Conner's questionnaire.
- Secondary Outcome Measures
Name Time Method